Acatavir Ltd Company was founded to develop the novel treatment of a feline disease called cat flu. What makes us special?? A vibrant researchers team, reliable IP protection, promising preliminary results, a professionally prepared research plan, and a substance with a known safety profile, used for pharmaceutical purposes in other indications.
CITTRU Center for Technology Transfer is a unit of the Jagiellonian University that is responsible for comprehensive collaboration between science and business. CITTRU is charged with such tasks as, among other things, identification of innovative solutions developed at the university, comprehensive legal protection of research results, investigation of the market potential of research results as well as selection of optimum commercialization methods in respect of scientific discoveries.
Dersmithson is primarily engaged in tissue engineering. The company develops technologies intended for use in cosmetics and medical devices. Dersmithson’s solutions, such as lift threads and fillers are used by esthetic medicine specialists. Regenerative medicine makes use of scaffolds made of natural substances. In order to maintain its pioneering position in the industry sector, the company actively works with foreign companies, including those based in South Korea, China, and European countries.
Discovery Life Sciences is a global leader in biological sample analysis, sourcing, distribution and scientific services for the pharmaceutical, biotechnology and diagnostics industries. Discovery Life Sciences combines the world’s largest commercial biospecimen inventory and supply network with outstanding multi-specialty services laboratories to accelerate precision medicine programs for cancer, infectious diseases and other complex conditions.
ExecMind is an international executive search boutique company, offering comprehensive services of recruitment for top scientist positions as well as senior and top management positions in Life Science, IT and high-tech sectors.
F1 Pharma Sp. z o. o. is a pharmaceutical company that provides research and development services. The founders of F1 Pharma boast proven academic track record and experience in working for the pharmaceutical industry, combined with complementary competencies in marketing medicinal products, quality control, product release and drug registration.
Gofarm is a Polish pharmaceutical company with an international reach, which has been specializing in products that improve the quality of life of patients for 13 years. It is an expert on the EU market in the development and production of pharmaceutical medical devices. It offers over 120 finished products in the private label formula – complete lines of medical devices, pharmaceutical cosmetics and dietary supplements. Their products are already in 40 countries around the world, and the number of satisfied partners is constantly growing. Gofarm also offers comprehensive R&D and Regulatory services for medical devices, including designing new products and adapting the existing ones to the required legal regulations (MDR 2017/745).
Klaster LifeScience was founded in 2006 as a joint initiative of businesses and institutions based in the Małopolskie Province. The primary objective of the cluster is to develop a collaboration network in the life science field, allowing for effective combination and utilization of the potential of businesses, institutions of higher education, research institutions as well as local authorities with a view to supporting the region’s entrepreneurship and innovation capability.
intoDNA is a growing biotech start-up that offers an end-to-end process for DNA break detection with STRIDE, its proprietary technology. It is the first platform technology for the direct detection of DNA ends, which translates into a better understanding of drug pharmacodynamic effects and their molecular mechanisms of action. The company has a broad client portfolio from tech hubs, such as Silicon Valley, Boston, or the Golden Triangle in the UK. This includes key pharmaceutical, biotech companies, and research teams at leading universities.
Jagiellonian Center for Experimental Therapeutics (JCET) is an interdisciplinary academic center for drug research and development, specializing in the development of innovative, interdisciplinary pharmacology of endothelium and blood vessel walls. JCET, which is an extra-faculty unit of the Jagiellonian University in Krakow, is Poland’s first academic center for drug research and development.
This is a Polish cosmetics manufacturer whose history dates back to the 1920s. The company primarily develops and sells cosmetics for facial and body care, perfumes, hair removal products as well as makeup products. Miraculum’s portfolio includes a total of 14 brands. In 2007 the company became listed on the Warsaw Stock Exchange.
NanoTemper Technologies offers an extensive range of high quality German-made products that facilitate effective and accurate protein characterization. The company’s product range includes systems, software and consumables for assessing binding affinity as well as protein stability and quality.
Owned by Orion Biotechnology Canada Ltd, Orion Biotechnology Polska is engaged in research on an innovative microbicide aimed at preventing the transmission of human immunodeficiency virus (HIV).
The Photo High Technologies company was established following many years of research on photopolymerization. The company specializes in the development and synthesis of photosensitizers, photostabilizers and colorants. Photo High Technologies is currently conducting research primarily designed to develop cationic photoinitiators active in visible light.
One of the most experienced stem cell banks on the Polish market. Since 2003, the bank has been collecting, preparing, testing and depositing stem cells from umbilical cord blood. It operates on the basis of the consent of the Minister of Health, providing services throughout the country. As the only bank in Poland, it has its own laboratory facilities and cooperates with a leading transplant center (Military Medical Institute in Warsaw).
Real Research is a young biotechnology company with a mission to promote 3D cell cultures. The company develops solutions for 3D cell cultures and new technologies for cell cultures. Real Research’s debut product is a hydrogel for 3D cell cultures.
Ryvu Therapeutics is a clinical stage biopharmaceutical company developing novel small molecule therapies addressing high value emerging targets in precision oncology. Ryvu Therapeuctis was founded in 2007 and currently employs 150 scientists, including 80 Ph.Ds. Ryvu was previously known as Selvita, until renamed to Ryvu Therapeutics after spin out of the services segment.
Their lead candidate, SEL120, is a selective CDK8 kinase inhibitor with potential for development in hematological malignancies and solid tumors, currently in Phase 1b study for the treatment of acute myeloid leukemia and myelodysplastic syndrome.
Selvita SA is Poland’s largest biotechnology company engaged in drug discovery and development. The company also offers laboratory contract research and development services to pharmaceutical, biotechnology and chemical companies all over the world. Selvita was established in 2007 and now it has a team of more than 500 associates, of whom 1/3 hold a doctoral degree. Since 2014 it has been listed on the Warsaw Stock Exchange. In March 2017 it became a SWIG80 index constituent company.
This company is the exclusive agent of SHIMADZU corporation in Poland. The company’s product offering comprises analytical and measuring instruments allowing for carrying out virtually all types of measurements used in analytics, starting from spectrophotometric and elemental analyses through mass chromatography and spectrometry and ending with spectroscopic surface analysis by means of high vacuum techniques. The company is also the exclusive distributor of apparatus produced by BIOTAGE, a company specializing in sample preparation products, and Phenomenex, which is a chromatography column and laboratory accessories manufacturer.
Synthos is one of Poland’s largest manufacturer of chemical raw materials. The Group’s business primarily involves selling chemical products used as raw materials and intermediate products in a wide range of industries, in particular the automotive, packaging and construction industries. The company is the first European manufacturer to start manufacture of synthetic rubbers as well as Europe’s largest polystyrene manufacturer.
SyVento is an expert in providing technologically advanced, innovative solutions for closing active substances. The company specializes in research and development of innovative raw materials for cosmetics and dietary supplements as well as pharmaceutical products based on the technology of encapsulation in lipid carriers (small molecule substances, nucleic acids). SyVento also deals with consulting and optimization of the production process of liposomes and lipid nanoparticles as well as mRNA synthesis.